Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study. [electronic resource]
Producer: 20030722Description: 580-5 p. digitalISSN:- 0923-7534
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Deoxycytidine -- administration & dosage
- Disease Progression
- Female
- Hemolytic-Uremic Syndrome -- chemically induced
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Neoplasm Metastasis
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Pancreatic Neoplasms -- drug therapy
- Survival
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.